| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/01/1999 | WO1999015158A2 REGULATION OF CELLULAR APOPTOSIS USING MODULATORS OF β-AR RECEPTORS |
| 04/01/1999 | WO1999015154A1 Methods for fabricating polymer-based controlled release preparations |
| 04/01/1999 | WO1999015153A1 Small particle liposome aerosols for delivery of anti-cancer drugs |
| 04/01/1999 | WO1999015150A1 Inorganic-polymer complexes for the controlled release of compounds including medicinals |
| 04/01/1999 | WO1999015130A2 Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same |
| 04/01/1999 | WO1999010373B1 Non-immunosuppressive cyclosporins and their use in the prevention and treatment of hiv infection |
| 04/01/1999 | WO1999003878A3 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis |
| 04/01/1999 | WO1999002704A3 Dual specifically phosphatase and methods of use |
| 04/01/1999 | WO1999002673A3 Antisense oligonucleotide sequences as inhibitors of microorganisms |
| 04/01/1999 | WO1999002567A3 Compositions and methods for producing homoconjugates of antibodies which induce growth arrest or apoptosis of tumor cells |
| 04/01/1999 | WO1999002564A3 Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same |
| 04/01/1999 | WO1999002552A3 Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof |
| 04/01/1999 | WO1999002545A3 Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 04/01/1999 | WO1999001551A3 Novel inhibitor of cellular proliferation |
| 04/01/1999 | WO1998058958A3 Human jagged polypeptide, encoding nucleic acids and methods of use |
| 04/01/1999 | WO1998057678A3 Compositions containing thrombin and microfibrillar collagen |
| 04/01/1999 | WO1998056812A3 Estrogen receptor crystals and ligands |
| 04/01/1999 | WO1998055615A9 Apaf-1, the ced-4 human homolog, an activator of caspase-3 |
| 04/01/1999 | WO1998055614A3 Secreted proteins and polynucleotides encoding them |
| 04/01/1999 | WO1998054313A3 Dna methyltransferase genomic sequences and antisense oligonucleotides |
| 04/01/1999 | WO1998054301A3 Transplants for myocardial scars and method and cellular preparations therefor |
| 04/01/1999 | WO1998053075A3 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 04/01/1999 | WO1998051787A3 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety |
| 04/01/1999 | WO1998051660A9 Methods and compositions for the selective modification of nucleic acids |
| 04/01/1999 | WO1998051321A9 Tissue factor for influencing blood vessel formation |
| 04/01/1999 | WO1998050430A3 Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging |
| 04/01/1999 | WO1998050425A3 Human tsc-22-like proteins |
| 04/01/1999 | WO1998048785A3 Allelic polygene diagnosis of reward deficiency syndrome and treatment |
| 04/01/1999 | WO1998044948B1 Intravenous immune globulin formulation containing a non-ionic surface active agent with improved pharmacokinetic properties |
| 04/01/1999 | WO1998039363A3 Immunotoxins and methods of inducing immune tolerance |
| 04/01/1999 | WO1998024482A3 Use of endothelin conjugates in therapy, new endothelin conjugates, substances containing them, and processes for producing them |
| 04/01/1999 | WO1998014592A3 Telomerase reverse transcriptase |
| 04/01/1999 | DE19743141A1 Combination of endothelin antagonist and inhibitor of angiotensin converting enzyme |
| 04/01/1999 | DE19741955A1 Mittel gegen bakterielle Meningitis Medicines for bacterial meningitis |
| 04/01/1999 | DE19734161A1 Antagonists of stroma cell-derived factor-1, for diagnosis and treatment of human immune deficiency virus (HIV) infection |
| 04/01/1999 | CA2305350A1 Costimulating polypeptide of t cells, monoclonal antibodies, and the preparation and use thereof |
| 04/01/1999 | CA2305016A1 Human complement c3-degrading proteinase from streptococcus pneumoniae |
| 04/01/1999 | CA2304843A1 Regulation of cellular apoptosis using modulators of .beta.-ar receptors |
| 04/01/1999 | CA2304615A1 Agents for combating bacterial meningitis |
| 04/01/1999 | CA2304485A1 Human regulatory molecules |
| 04/01/1999 | CA2304396A1 A pharmaceutical preparation comprising vitamin k-dependent single factors |
| 04/01/1999 | CA2304384A1 Fibrin microbeads and uses thereof |
| 04/01/1999 | CA2304268A1 Transgenic autologous t-cell therapy in humans, and related compositions and kits |
| 04/01/1999 | CA2304131A1 Method for gene transfer using bcl2 and compositions useful therein |
| 04/01/1999 | CA2304129A1 Tie ligand homologues |
| 04/01/1999 | CA2304126A1 Cell growth regulator |
| 04/01/1999 | CA2303924A1 Method for purification of antithrombin iii |
| 04/01/1999 | CA2303762A1 Megsin protein |
| 04/01/1999 | CA2303405A1 53bp2 complexes |
| 04/01/1999 | CA2303147A1 Small particle liposome aerosols for delivery of anti-cancer drugs |
| 04/01/1999 | CA2303003A1 Ucp3 genes |
| 04/01/1999 | CA2302993A1 Mutants of thyroid stimulating hormone and methods based thereon |
| 04/01/1999 | CA2302936A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 04/01/1999 | CA2302806A1 Macrophage derived chemokine (mdc), mdc analogs, mdc inhibitor substances, and uses thereof |
| 04/01/1999 | CA2302778A1 Dna vaccination against cholesterol ester transfer protein in the treatment of atherosclerosis |
| 04/01/1999 | CA2301957A1 Antisense oligonucleotides against thymidylate synthase |
| 04/01/1999 | CA2301693A1 Cytokines having neurotrophic activity |
| 04/01/1999 | CA2301614A1 Thrombin inhibitors |
| 04/01/1999 | CA2246004A1 A kringle-related clone, hthbz47 |
| 03/31/1999 | EP0905253A2 Adenoviral vector deleted of all E4-ORF except ORF6 |
| 03/31/1999 | EP0905250A1 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratA |
| 03/31/1999 | EP0905249A2 Alcohol dehydrogenase |
| 03/31/1999 | EP0905248A1 Staphylococcus aureus MurE protein and nucleic acids encoding it |
| 03/31/1999 | EP0905247A2 MurF polynucleotides and polypeptides from Staphylococcus |
| 03/31/1999 | EP0905246A1 Cloning of chicken anaemia DNA |
| 03/31/1999 | EP0905245A1 Staphylococcal polypeptides Spo0J1 |
| 03/31/1999 | EP0905244A2 FolC from Streptococcus |
| 03/31/1999 | EP0905243A2 Polynucleotides from Staphylococcus aureus expressed in infected tissue |
| 03/31/1999 | EP0905241A1 Amino-terminally truncated c-c chemokines as chemokine antagonists |
| 03/31/1999 | EP0905240A1 Amino-terminally truncated c-c chemokines as chemokine antagonists |
| 03/31/1999 | EP0905238A2 Pigrl-1, a member of immunoglobin gene superfamily |
| 03/31/1999 | EP0905237A2 PIGR-2 A member of immunoglobulin gene superfamily |
| 03/31/1999 | EP0905235A2 Vascular smooth muscle cell growth factor |
| 03/31/1999 | EP0905234A2 Allelic variant of human STAT3 |
| 03/31/1999 | EP0905233A2 Staphylococcus aureus trigger factor |
| 03/31/1999 | EP0905143A2 Complex of human growth hormone and zinc and use |
| 03/31/1999 | EP0905142A1 Inhibitors against prostate-specific antigen |
| 03/31/1999 | EP0905141A1 Peptide fragment of the limulus anti-LPS factor (LALF) having antiviral action |
| 03/31/1999 | EP0905139A2 5 ring heterocyles, process for preparation, use as inhibitors of leukocyte adhesion and pharmaceutical preparations comprising them |
| 03/31/1999 | EP0904787A1 Scleral plug containing proteinaceous medicine |
| 03/31/1999 | EP0904785A1 Protein C inhibitor against hypercoagulation |
| 03/31/1999 | EP0904539A1 Inhibiting protein interactions |
| 03/31/1999 | EP0904410A1 Identification of pyrazinamide-resistant mycobacteria and methods for treating mycobacterial infections |
| 03/31/1999 | EP0904398A1 Chemokine alpha 3 |
| 03/31/1999 | EP0904384A2 Tyrosine-phosphatase-related protein |
| 03/31/1999 | EP0904382A1 Characterization and use of an isolated uridine diphospho-glucuronosyltransferase |
| 03/31/1999 | EP0904381A2 Compositions and methods relating to drug discovery and detection and treatment of gastrointestinal diseases |
| 03/31/1999 | EP0904378A1 Hepatitis b monoclonal antibodies |
| 03/31/1999 | EP0904374A1 Processed polypeptides with il-16 activity, process for preparing the same and their use |
| 03/31/1999 | EP0904373A1 Targeted delivery of genes encoding interferon |
| 03/31/1999 | EP0904372A2 Human phospholipase inhibitor |
| 03/31/1999 | EP0904370A1 Methods for recombinant microbial production of bpi-fusion proteins and bpi-derived peptides |
| 03/31/1999 | EP0904369A1 Autoantigen and proteins structurally related thereto for use in immunotherapy of autoimmune diseases |
| 03/31/1999 | EP0904368A1 Al-2 neurotrophic factor |
| 03/31/1999 | EP0904367A1 Scf analog compositions and methods |
| 03/31/1999 | EP0904366A1 Apo-2li and apo-3 apoptosis polypeptides |
| 03/31/1999 | EP0904365A1 Antigenically reactive regions of the hepatitis-a virus polyprotein |
| 03/31/1999 | EP0904359A1 AN ENZYME WITH $g(b)-1,3-GLUCANASE ACTIVITY |
| 03/31/1999 | EP0904352A1 Cell line |
| 03/31/1999 | EP0904349A1 Transgenic non-human mammals with progressive neurologic disease |